Aplantex Raises $ 1.3 M in Initial Round of Financing

Mr. Patrick Charest, B. Sc., P. Eng., Aplantex's CEO is pleased to announce that its initial round of financing was successfully completed. The company has managed to raise $ 1.3 M in start-up funds. This is a clear signal that its innovative and exclusive process and sound business model answer a clear market need. "The money will be used to ramp up the research laboratory, set up an initial production line, and to plan large-scale commercial production," underlines Mr. Charest. "Aplantex is in full growth mode. Our team is committed to supplying companies having products that cater to the health, beauty, and nutrition needs of individuals with the essential molecules they require albeit at a lower cost than other production methods while also simplifying the supply chain and working within ESG parameters," concludes Mr. Charest.

ABOUT APLANTEX

The Aplantex scientific team has developed a unique process to produce certified high-value molecules that enjoy strong demand from major players in many industries. The core of this green biotechnology process for efficient and sustainable phytochemistry consists of the continuous production in a controlled environment of biomass originating from photosynthetic plant replicators. This abundant biomass is dried and the extraction, fragmentation, and purification stages allow the separation of the specific molecules essential to the production of popular products in the health, beauty, and food industries.

The photosynthetic plant replicators can store up to 40% of their dry weight of atmospheric CO₂ and, in Quebec, can be grown year-round in a controlled environment using sustainable hydroelectric power. With its eco-friendly process, Aplantex is thus a preferred supplier for any company looking to comply with ESG criteria.